Hong Kong-listed biopharma stocks rallied after ten Chinese ministries issued
the pharmaceutical industry "15th Five-Year Plan." GenScript Biotech (01548.HK)
rose over 5%, Zai Lab (09688.HK) gained nearly 5%; Junshi Biosciences
(01877.HK), Henlius Biotech (02696.HK), Tigermed (03347.HK) and WuXi AppTec
(02359.HK) also moved higher.